PRKD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.102630E-01
Normal-vs-Stage2
3.809600E-01
Normal-vs-Stage3
3.548000E-01
Normal-vs-Stage4
8.869600E-01
Stage1-vs-Stage2
3.717400E-01
Stage1-vs-Stage3
6.327800E-01
Stage1-vs-Stage4
2.837200E-01
Stage2-vs-Stage3
7.247800E-01
Stage2-vs-Stage4
1.948240E-01
Stage3-vs-Stage4
3.641600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.674600E-01
Normal-vs-AfricanAmerican
6.823000E-01
Normal-vs-Asian
3.958600E-01
Caucasian-vs-AfricanAmerican
8.304200E-01
Caucasian-vs-Asian
5.656400E-01
AfricanAmerican-vs-Asian
4.555000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.907600E-01
Normal-vs-Female
2.923400E-01
Male-vs-Female
3.268600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.321400E-01
Normal-vs-Age(41-60Yrs)
6.375000E-01
Normal-vs-Age(61-80Yrs)
6.879800E-01
Normal-vs-Age(81-100Yrs)
3.199600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.068400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.983800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.350600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.252600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.809390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.073400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.784190E-01
Normal-vs-Daily Drinker
1.147830E-01
Normal-vs-Weekly Drinker
8.523000E-01
Normal-vs-Occasional Drinker
5.880600E-01
Normal-vs-Social Drinker
6.890800E-01
Non Drinker-vs-Daily Drinker
8.183000E-01
Non Drinker-vs-Weekly Drinker
6.340000E-02
Non Drinker-vs-Occasional Drinker
1.548770E-01
Non Drinker-vs-Social Drinker
1.189210E-01
Daily Drinker-vs-Weekly Drinker
1.178220E-01
Daily Drinker-vs-Occasional Drinker
1.887030E-01
Daily Drinker-vs-Social Drinker
1.372360E-01
Weekly Drinker-vs-Occasional Drinker
5.949800E-01
Weekly Drinker-vs-Social Drinker
7.518800E-01
Occasional Drinker-vs-Social Drinker
8.371600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.676000E-01
Normal-vs-Grade 2
2.947000E-01
Normal-vs-Grade 3
3.772000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.017400E-01
Grade 1-vs-Grade 3
2.573600E-01
Grade 1-vs-Grade 4
5.676000E-01
Grade 2-vs-Grade 3
3.309600E-01
Grade 2-vs-Grade 4
2.947000E-01
Grade 3-vs-Grade 4
3.772000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.337400E-01
Normal-vs-NonDiabetic
7.155800E-01
Diabetic-vs-NonDiabetic
4.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.241200E-01
Normal-vs-NoPancreatitis
6.917600E-01
Pancreatitis-vs-NoPancreatitis
2.963600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.431400E-01
Normal-vs-N1
4.129800E-01
N0-vs-N1
6.063600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.144200E-01
Normal-vs-TP53-NonMutant
8.563400E-01
TP53-Mutant-vs-TP53-NonMutant
1.280630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
